Key clinical point: Gene therapy engraftment was achieved sooner using intrabone delivery.
Major finding: After a median of 16 months of follow-up, five of seven patients who received this novel gene therapy needed markedly fewer blood transfusions than at baseline.
Data source: An interventional phase 1/2 trial of seven patients with transfusion-dependent beta thalassemia.
Disclosures: Telethon Foundation provided funding. Dr. Marktel disclosed research funding from GlaxoSmithKline, which has licensed the therapy.
Source: Marktel S et al. ASH 2017 Abstract 355.
Marktel S et al. ASH 2017 Abstract 355
This Week's Must Reads
Monetary support affects select prescribing, Mitchell AP et al. JAMA Intern Med. 2018 Apr 9. doi: 0.1001/jamainternmed.2018.0776
Best TKI options in ALL, Jabbour E et al. Clin Lymphoma Myeloma Leuk. 2018 18(4):257-65
2 approaches to diagnosing heparin-induced thrombocytopenia, Pishko A et al. Biennial summit of the Thrombosis & Hemostasis Societies of North America (THSNA) 2018, Abstract 103
Blinatumomab eliminates residual B-cell ALL, Gökbuget N et al. Blood. 2018 Apr 5;131(14):1522-31.
Aryl hydrocarbon receptor antagonist boosts cord blood engraftment, Wagner J et al. 2018 Bone Marrow Transplant Tandem Meetings, Abstract 4.
Must Reads in Bleeding Disorders
Mild thrombocytopenia linked to higher bleeding risk after percutaneous coronary interventions, Ito S et al. Am J Cardio published online March 1 https://doi.org/10.1016/j.amjcard.2018.02.010
Questionnaires discern epistaxis severity and pattern in children, Stokhuijzen E et al. J Pediatr 2018;193:183-9 https://doi.org/10.1016/j.jpeds.2017.09.082
Thyroid disorders, hepatitis incidence high in immune thrombocytopenia, Wu S et al. Thrombosis Research 2018 April, 90-95 https://doi.org/10.1016/j.thromres.2018.02.146
Platelet changes in long-term SSRI users, Aleksovski B et al. Thrombosis Research 165 (2018) 24-32.
Plasminogen replacement therapy in congenital plasminogen deficiency, Shapiro A et al. Blood 2018 131:1301-1310; doi: https://doi.org/10.1182/blood-2017-09-806729